NYSE: NVO       Novo Nordisk A/S
Last Price Today's Change   Day's Range   Trading Volume
57.92   +0.28 (0.49%)  57.23 - 57.935  904,187


Avg Volume (4 weeks):1,301,405
4 Weeks Range:51.96 - 57.935
4 Weeks Price Volatility (%):
52 Weeks Range:43.115 - 57.935
52 Weeks Price Volatility (%):
Average Price Target: 193.60
Price Target Upside/Downside: +135.68


No recent Headlines for this stock.

Business Background

Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.

  Be the first to like this.


2988  2548  420  3021 

Top 10 Active Counters
 FCEL 0.909+0.099 
 CHK 0.696-0.005 
 AMD 38.335+0.815 
 CSCO 44.685-3.775 
 AABA 19.630.00 
 CPE 4.29-0.17 
 SNNA 0.30+0.14 
 NIO 1.73-0.17 
 NOK 3.354-0.116 
 AMRN 21.490.00 
Partners & Brokers